Clinical trial / 2006
Daily fresh red grapefruit supplementation reduced total cholesterol, LDL cholesterol, and triglycerides in post-coronary bypass hyperlipidemic patients.
Fifty-seven hyperlipidemic patients following coronary bypass surgery were randomly divided into three groups of 19: red grapefruit, blond grapefruit, or control for 30 consecutive days. Compared to the control group, patients receiving red and blond grapefruit showed reductions in total cholesterol (15.5% and 7.6%), LDL cholesterol (20.3% and 10.7%), and triglycerides (17.2% and 5.6%), respectively. No changes in serum lipid levels were observed in the control group. In vitro analyses also showed red grapefruit had higher contents of bioactive compounds and antioxidant potential than blond grapefruit.
- Study type
- Randomized controlled trial
- Who was studied
- 57 hyperlipidemic patients, ages 39-72 years, after coronary bypass surgery
- What was measured
- Serum lipid levels and serum antioxidant activity
THE PAPER
Red grapefruit positively influences serum triglyceride level in patients suffering from coronary atherosclerosis: studies in vitro and in humans.
Gorinstein S, Caspi A, Libman I, Lerner HT, Huang D, Leontowicz H, Leontowicz M, Tashma Z, Katrich E, Feng S, Trakhtenberg S. J Agric Food Chem, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.